PRELUDE CAPITAL MANAGEMENT, LLC - CYCLERION THERAPEUTICS INC ownership

CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 70 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CYCLERION THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$80,000
+15.9%
92,541
-26.7%
0.00%
+50.0%
Q2 2022$69,000
-37.8%
126,192
+25.9%
0.00%
-33.3%
Q1 2022$111,000
-16.5%
100,255
+29.2%
0.00%0.0%
Q4 2021$133,000
+1.5%
77,583
+82.4%
0.00%0.0%
Q3 2021$131,000
-32.8%
42,542
-15.1%
0.00%
-50.0%
Q2 2021$195,000
+1525.0%
50,104
+4910.4%
0.01%
+500.0%
Q3 2019$12,0001,0000.00%
Other shareholders
CYCLERION THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AWH Capital, L.P. 590,000$1,605,0001.87%
MFN Partners Management, LP 1,487,874$4,047,0000.83%
EcoR1 Capital, LLC 1,811,000$4,926,0000.44%
Madison Avenue Partners, LP 132,569$361,0000.31%
Artal Group S.A. 1,361,584$3,703,0000.14%
TRUSTCORE FINANCIAL SERVICES, LLC 198,106$539,0000.10%
Alambic Investment Management, L.P. 44,266$120,0000.10%
Broderick Brian C 32,175$88,0000.03%
HORIZON KINETICS ASSET MANAGEMENT LLC 129,311$352,0000.01%
Sawyer & Company, Inc 4,100$11,0000.01%
View complete list of CYCLERION THERAPEUTICS INC shareholders